{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T16:02:00Z","timestamp":1785340920862,"version":"3.55.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n Importance<\/jats:title>\n State-level dense breast legislation aims to increase awareness of breast density and promote supplemental imaging, yet the association of specific legislation type with imaging use remains unclear.<\/jats:p>\n <\/jats:sec>\n \n Objectives<\/jats:title>\n To evaluate the differential association of dense breast notification and insurance coverage laws with supplemental imaging use and to assess how specific legislative features are associated with imaging use.<\/jats:p>\n <\/jats:sec>\n \n Design, Setting, and Participants<\/jats:title>\n This retrospective, quasi-experimental cohort study used data from the MarketScan database, one of the largest national administrative claims databases in the US, from January 1, 2008, through December 31, 2019. A total of 12.6 million women aged 40 to 64 years undergoing screening mammography with continuous insurance enrollment for at least 6 months after the index screening mammography were followed up for up to 6 months after the screening mammography. Data were analyzed from January to July 2025.<\/jats:p>\n <\/jats:sec>\n \n Intervention<\/jats:title>\n Dense breast legislation, including notification and insurance coverage laws.<\/jats:p>\n <\/jats:sec>\n \n Main Outcomes and Measures<\/jats:title>\n Receipt of supplemental ultrasonography or magnetic resonance imaging (MRI) within 6 months of screening mammography. Multivariable logistic regression with an extended difference-in-differences design was used to assess within-state changes over time, leveraging variation in the timing of policy adoption across states.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Of 12\u202f555\u202f082 women (mean [SD] age, 51.3 [6.9] years) undergoing mammography, 9.0% received supplemental ultrasonography and 0.6% received supplemental MRI. Notification mandates were associated with higher use of ultrasonography (odds ratio [OR], 1.09; 95% CI, 1.08-1.10) and MRI (OR, 1.09; 95% CI, 1.06-1.12). Insurance coverage was associated with higher odds of supplemental ultrasonography use (OR, 1.88; 95% CI, 1.86-1.90). Among states with notification mandates, including information on supplemental screening (OR, 2.84; 95% CI, 2.81-2.86) and targeting notification only to women with dense breasts (OR, 1.32; 95% CI, 1.31-1.33) were both associated with higher odds of ultrasonography use.<\/jats:p>\n <\/jats:sec>\n \n Conclusions and Relevance<\/jats:title>\n In this cohort study of women undergoing mammography, both dense breast notification and insurance coverage laws were associated with increased use of supplemental ultrasonography, with greater odds observed for insurance mandates. Specific legislative features, particularly targeted notification and inclusion of supplemental screening information, were also associated with increased use of supplemental ultrasonography. Further studies covering wider populations and integrating claims data with clinical registries, imaging reports, or electronic health records are needed to better delineate the association between dense breast legislation and supplemental screening behavior.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.26008","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:30:24Z","timestamp":1785339024000},"page":"e2626008","source":"Crossref","is-referenced-by-count":0,"title":["Dense Breast Legislation and Supplemental Breast Imaging Among Women Undergoing Mammography"],"prefix":"10.1001","volume":"9","author":[{"given":"Dong-Won","family":"Kang","sequence":"first","affiliation":[{"name":"College of Pharmacy, Ajou University, Suwon, Republic of Korea"},{"name":"Department of Biohealth Regulatory Science, Graduate School of Ajou University, Suwon, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Chetlen","sequence":"additional","affiliation":[{"name":"Department of Radiology, Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhao","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Leslie","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania"},{"name":"Department of Surgery, Penn State College of Medicine, Hershey, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"issue":"4","key":"zoi260718r1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"zoi260718r2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1056\/NEJMoa062790","article-title":"Mammographic density and the risk and detection of breast cancer.","volume":"356","author":"Boyd","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"zoi260718r3","doi-asserted-by":"publisher","DOI":"10.1093\/jncics\/pkae103","article-title":"Clinical guidelines for the management of mammographic density: a systematic review of breast screening guidelines worldwide.","volume":"8","author":"Isautier","year":"2024","journal-title":"J Natl Cancer Inst Cancer Spectr"},{"issue":"6","key":"zoi260718r4","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1093\/jbi\/wbad034","article-title":"Implementing the national dense breast reporting standard, expanding supplemental screening using current guidelines, and the proposed Find It Early Act.","volume":"5","author":"Berg","year":"2023","journal-title":"J Breast Imaging"},{"issue":"5S","key":"zoi260718r5","doi-asserted-by":"publisher","first-page":"S405","DOI":"10.1016\/j.jacr.2025.02.023","article-title":"ACR Appropriateness Criteria\u00ae supplemental breast cancer screening based on breast density: 2024 update.","volume":"22","author":"Paulis","year":"2025","journal-title":"J Am Coll Radiol"},{"issue":"1","key":"zoi260718r8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s10549-021-06203-w","article-title":"The impact of mandatory mammographic breast density notification on supplemental screening practice in the United States: a systematic review.","volume":"187","author":"Huang","year":"2021","journal-title":"Breast Cancer Res Treat"},{"issue":"15","key":"zoi260718r9","doi-asserted-by":"publisher","first-page":"5662","DOI":"10.1002\/cam4.3218","article-title":"Breast cancer supplemental screening: women\u2019s knowledge and utilization in the era of dense breast legislation.","volume":"9","author":"Aminawung","year":"2020","journal-title":"Cancer Med"},{"issue":"1","key":"zoi260718r10","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/tbj.12053","article-title":"Real world performance of screening breast ultrasound following enactment of Connecticut bill 458.","volume":"19","author":"Parris","year":"2013","journal-title":"Breast J"},{"issue":"10","key":"zoi260718r11","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.jacr.2016.05.005","article-title":"Impact of the New Jersey breast density law on imaging and intervention volumes and breast cancer diagnosis.","volume":"13","author":"Sanders","year":"2016","journal-title":"J Am Coll Radiol"},{"issue":"10","key":"zoi260718r12","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.jacr.2015.04.015","article-title":"Breast density legislation: discussion of patient utilization and subsequent direct financial ramifications for insurance providers.","volume":"12","author":"Sobotka","year":"2015","journal-title":"J Am Coll Radiol"},{"issue":"8","key":"zoi260718r13","doi-asserted-by":"publisher","first-page":"1441","DOI":"10.1007\/s11606-019-05026-2","article-title":"The impact of breast density notification laws on supplemental breast imaging and breast biopsy.","volume":"34","author":"Saulsberry","year":"2019","journal-title":"J Gen Intern Med"},{"issue":"7624","key":"zoi260718r15","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.","volume":"335","author":"von Elm","year":"2007","journal-title":"BMJ"},{"issue":"6","key":"zoi260718r16","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","article-title":"Updating and validating the Charlson Comorbidity Index and score for risk adjustment in hospital discharge abstracts using data from 6 countries.","volume":"173","author":"Quan","year":"2011","journal-title":"Am J Epidemiol"},{"issue":"1","key":"zoi260718r18","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jacr.2009.09.022","article-title":"Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.","volume":"7","author":"Lee","year":"2010","journal-title":"J Am Coll Radiol"},{"issue":"6","key":"zoi260718r19","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1016\/j.amepre.2021.05.020","article-title":"Association between dense breast legislation and cancer stage at diagnosis.","volume":"61","author":"Shen","year":"2021","journal-title":"Am J Prev Med"},{"issue":"2","key":"zoi260718r20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jeconom.2020.09.006","article-title":"Estimating dynamic treatment effects in event studies with heterogeneous treatment effects.","volume":"225","author":"Sun","year":"2021","journal-title":"J Econom"},{"issue":"2","key":"zoi260718r21","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1177\/1077558717751941","article-title":"Dense breast notification laws: impact on downstream imaging after screening mammography.","volume":"77","author":"Horn\u00fd","year":"2020","journal-title":"Med Care Res Rev"},{"issue":"5","key":"zoi260718r22","doi-asserted-by":"publisher","first-page":"762","DOI":"10.2105\/AJPH.2019.304967","article-title":"Association of state dense breast notification laws with supplemental testing and cancer detection after screening mammography.","volume":"109","author":"Busch","year":"2019","journal-title":"Am J Public Health"},{"issue":"4","key":"zoi260718r23","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.5295","article-title":"Colorectal cancer screening after sequential outreach components in a demographically diverse cohort.","volume":"7","author":"Podmore","year":"2024","journal-title":"JAMA Netw Open"},{"issue":"10","key":"zoi260718r24","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.7326\/ANNALS-24-03144","article-title":"Effect of personalized risk messages on uptake of colorectal cancer screening: a randomized controlled trial.","volume":"178","author":"Schwartz","year":"2025","journal-title":"Ann Intern Med"},{"key":"zoi260718r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106918","article-title":"Two randomized controlled trials for colorectal cancer screening invitations developed using a behavioral science approach.","volume":"155","author":"Tinmouth","year":"2022","journal-title":"Prev Med"},{"issue":"4","key":"zoi260718r26","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/tbj.12594","article-title":"The role of magnetic resonance imaging in the investigation and management of invasive lobular carcinoma\u2014a 3-year retrospective study in two district general hospitals.","volume":"22","author":"Derias","year":"2016","journal-title":"Breast J"},{"issue":"1","key":"zoi260718r27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/jbi\/wbab088","article-title":"Recent trends in screening breast MRI.","volume":"4","author":"Lee","year":"2021","journal-title":"J Breast Imaging"},{"issue":"9","key":"zoi260718r28","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/ans.19140","article-title":"Is staging breast magnetic resonance imaging for invasive lobular carcinoma worthwhile?","volume":"94","author":"Melvin","year":"2024","journal-title":"ANZ J Surg"},{"key":"zoi260718r29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2024.111837","article-title":"Extremely dense breasts: a comprehensive review of increased cancer risk and supplementary screening methods.","volume":"182","author":"Nissan","year":"2025","journal-title":"Eur J Radiol"},{"issue":"2","key":"zoi260718r30","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1093\/jnci\/djab150","article-title":"Cost-sharing and out-of-pocket cost for women who received MRI for breast cancer screening.","volume":"114","author":"Pan","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"zoi260718r6","unstructured":"State law insurance map. Dense Breast Info. Accessed July 23, 2025. https:\/\/densebreast-info.org\/legislative-information\/state-law-insurance-map\/"},{"key":"zoi260718r7","unstructured":"Important information: final rule to amend the Mammography Quality Standards Act (MQSA). US Food and Drug Administration. September 10, 2024. Accessed December 17, 2025. https:\/\/www.fda.gov\/radiation-emitting-products\/mammography-quality-standards-act-mqsa-and-mqsa-program\/important-information-final-rule-amend-mammography-quality-standards-act-mqsa"},{"key":"zoi260718r14","unstructured":"MarketScan databases. Merative. Accessed June 13, 2025. https:\/\/www.merative.com\/real-world-evidence"},{"key":"zoi260718r17","unstructured":"Position statement on screening mammograms. The American Society of Breast Surgeons. Accessed September 3, 2025. https:\/\/www.breastsurgeons.org\/docs\/statements\/asbrs-ppr-screening-mammography.pdf"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2852220\/kang_2026_oi_260718_1784730450.13152.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:30:28Z","timestamp":1785339028000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2852220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.26008","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]}}}